Minovia Therapeutics
PrivateLast Round
M&A
Jan 30, 2026
Total Funding Raised
$36M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Minovia Therapeutics is a clinical-stage biotechnology company that develops novel therapies to treat mitochondrial diseases and combat age-related decline using its proprietary Mitochondrial Augmentation Therapy (MAT) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Minovia Therapeutics Comparables
Compare Minovia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PAEAN Biotechnology | 80% | |
| cellvie | 78% | |
| Taiwan Mitochondrion Applied Technology Co., Ltd. | 77% |
Minovia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Jan 30, 2026 | ||||
| Grant | Aug 27, 2025 | ||||
| Corporate Funding | Jul 30, 2021 | ||||
| Series A | Dec 1, 2018 |
Minovia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Launch One Acquisition Corp. | M&A |
| Countdown For A Cure Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 12, 3x the trailing average.
- Jul 20, 2026
Open roles increased from 0 to 12, representing 50% of headcount.
Minovia Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Minovia Therapeutics's valuation, stock price, and market status.
Is Minovia Therapeutics a public or private company?
Minovia Therapeutics is a private company.
What is the current stock price of Minovia Therapeutics?
Minovia Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Minovia Therapeutics worth (valuation)?
Valuation information for Minovia Therapeutics is not publicly available.
Can I buy Minovia Therapeutics stock?
Minovia Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Minovia Therapeutics's last funding round?
Minovia Therapeutics's most recent funding round was M&A on January 30, 2026.
Who are the main investors in Minovia Therapeutics?
Key investors in Minovia Therapeutics include Launch One Acquisition Corp., Countdown For A Cure Foundation.
Will Minovia Therapeutics IPO soon?
No public IPO plans have been announced for Minovia Therapeutics.
How can I track Minovia Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Minovia Therapeutics's secondary market activity and sign up for updates.